Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Inturrisi

Showing results (51-60 of 152) with videos related to

Pageof 16
Sort By:
Archives of General Psychiatry|August 1, 1983
Methadyl acetate (LAAM) in the treatment of heroin addicts. II. Double-blind comparison of gradual and abrupt detoxificationB A Judson, A Goldstein, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1986
Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the ratB C Yoburn, A H Cohen, C E Inturrisi
Neuroscience Letters|August 25, 1995
Differential regulation of c-fos, proenkephalin and tyrosine hydroxylase gene expression by metrazole in the hamster adrenal and hippocampusY S Zhu, S O Franklin, C E Inturrisi
Life Sciences|February 13, 1984
Methadone induced physical dependence in the ratG S Ling, N S Tappe, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1981
Methadone: radioimmunoassay and pharmacokinetics in the ratG S Ling, J G Umans, C E Inturrisi
Neuroscience Letters|February 14, 1997
The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cordA L Gorman, K J Elliott, C E Inturrisi
Journal of Neurochemistry|May 1, 1994
Acute and persistent suppression of preproenkephalin mRNA expression in the striatum following developmental hypoxic-ischemic injuryR E Burke, S O Franklin, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioidsB Kest, G McLemore, B Kao, et al.
Annals of Neurology|August 1, 1986
Cerebrospinal fluid pharmacokinetics of intrathecal morphine sulfate and D-Ala2-D-Leu5-enkephalinD E Moulin, C E Inturrisi, K M Foley
Brain Research Bulletin|January 1, 1995
CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexoneM Brodsky, K Elliott, A Hynansky, et al.
Pageof 16

Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Archives of General Psychiatry|August 1, 1983
Methadyl acetate (LAAM) in the treatment of heroin addicts. II. Double-blind comparison of gradual and abrupt detoxificationB A Judson, A Goldstein, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1986
Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the ratB C Yoburn, A H Cohen, C E Inturrisi
Neuroscience Letters|August 25, 1995
Differential regulation of c-fos, proenkephalin and tyrosine hydroxylase gene expression by metrazole in the hamster adrenal and hippocampusY S Zhu, S O Franklin, C E Inturrisi
Life Sciences|February 13, 1984
Methadone induced physical dependence in the ratG S Ling, N S Tappe, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1981
Methadone: radioimmunoassay and pharmacokinetics in the ratG S Ling, J G Umans, C E Inturrisi
Neuroscience Letters|February 14, 1997
The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cordA L Gorman, K J Elliott, C E Inturrisi
Journal of Neurochemistry|May 1, 1994
Acute and persistent suppression of preproenkephalin mRNA expression in the striatum following developmental hypoxic-ischemic injuryR E Burke, S O Franklin, C E Inturrisi
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioidsB Kest, G McLemore, B Kao, et al.
Annals of Neurology|August 1, 1986
Cerebrospinal fluid pharmacokinetics of intrathecal morphine sulfate and D-Ala2-D-Leu5-enkephalinD E Moulin, C E Inturrisi, K M Foley
Brain Research Bulletin|January 1, 1995
CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexoneM Brodsky, K Elliott, A Hynansky, et al.
Pageof 16